Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics

European Respiratory Journal

Volumn 13, Issue 3, 1999, Pages 638-646

  Schafer D ^a   Schmid, M ^a   Gode U C ^a   Baenkler, H W ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Aspirin induced asthma; Histamine; Human prostaglandin E2; Peptidoleukotrienes

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; HISTAMINE; ICOSANOID; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN E2;

ADULT; ARACHIDONIC ACID METABOLISM; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; ENZYME IMMUNOASSAY; FEMALE; FORCED EXPIRATORY VOLUME; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

EID: 18344399925     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.99.13363899     Document Type: Article

References (32)

1. Samter M, Beers RF. Intolerance to aspirin. Clinical studies and considerations of its pathogenesis. Ann Intern Med 1968; 60: 276-284.
2. Widal F, Abrami P, Lermoyez J. Anaphylaxie et idiosyncrasie. Presse Med 1922; 30: 189-193.
3. Stevenson DD, Simon RA. Aspirin sensitivity: respiratory and cutaneous manifestations. In: Meddleton E Jr, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, eds. Allergy: Principles and Practice. St Louis, CV Mosby, 1988; pp. 1537-1554.
4. 2 and aspirin-induced asthma. Lancet 1995; 345: 1056.
5. Weiss JW, Drazen JM, Coles N. Bronchoconstrictor effects of leukotriene C in humans. Science 1982; 216: 196-198.
6. Sladek K, Dworski R, Soja J, et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994; 149: 940-946.
7. Picado C, Ramis I, Rosello J, et al. Release of peptide leukotriene into nasal secretions after local instillation of aspirin-sensitive asthmatic patients. Ann Rev Respir Dis 1992; 145: 65-69.
8. Fischer AR, Rosenberg MA, Lilly CM, et al. Direct evidence for a role of mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 1994; 94: 1046-1056.
9. 4, and histamine in asthmatics. Am Rev Respir Dis 1992; 146: 96-103.
10. Smith CM, Hawksworth RJ, Thien FCK, Chrisrie PE, Lee TH. Urinary leukotriene E4 in bronchial asthma. Eur Respir J 1992; 5: 693-699.
11. Christie PE, Tgagari P, Ford-Hudchinson AW, et al. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Am Rev Respir Dis 1992; 146: 1531-1534.
12. Bonne C, Moneret-Vautrin DA, Wayhoff M, et al. Arachidonic acid metabolism and inhibition of cyclooxygenase in platelets from asthmatic subjects with aspirin intolerance. Ann Allergy 1985; 54: 158-160.
13. Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL. Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challange. Allergy Clin Immunol 1992; 90: 636-645.
14. Sladek K., Szczelklik A. Cysteinyl leukotrienes over-production and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J 1993; 6: 391-399.
15. Dahlén B, Dahlén SE. Intolerance reactions to NSAIDs. In: Basomba A, Sastre J, eds. XVI European congress of allergology and clinical immunology ECACI '95, Proceedings I. Bologna, Monduzzi Editore, 1995; pp. 821-828.
16. 2. Lancet 1995; 345: 436-438.
17. William WR, Pawlowicz A, Davies B. In vitro test for the diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol 1990; 86: 445-451.
18. Ferreri NR, Howland WC, Stevenson DD, Spiegelberg HL. Release of leukotrienes, prostagalndins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 1988; 137: 847-854.
19. Schmitz-Schumann M, Schaub E, Virchow C. Inhalative Provakation mit Lysine-Acetylsäure beim Analgetika-Asthma-Syndrom. Prax Klin Pneumol 1982; 36: 17-21.
20. Stevenson DD, Pleskow WW, Simon RA, et al. Aspirin sensitive rhinosinositis asthma: a double blind crossover study of treatment with aspirin. J Allergy Clin Immunol 1984; 73: 500-507.
21. Smith WL. Prostanoid biosynthesis and mechanisms of activation. Am J Physiol 1992; 263: F181-F190.
22. 4. Biochim Biophys Acta 1991; 1081: 274-278.
23. Brune K, Reinke M, Lanz R, Peskar BA. Monoclonal antibodies against E- and F-type prostaglandins. FEBS Lett 1985; 186: 46-50.
24. 2 on eicosanoid release by human bronchial biopsy specimens from normal and inflamed mucosa. Thorax 1996; 51: 919-923.
25. Marcus AJ. Eicosanoids: transcellular metabolism. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. New York, Raven Press, 1988; pp. 129-137.
26. Samuelsson B, Goldyne M, Granström E, Hamberg M, Mannerström S, Malmsten C. Prostaglandins and thromboxanes. Ann Rev Biochem 1978; 47: 997-1029.
27. Ham EA, Soderman DD, Zanetti ME, Dougherty HW, McCauley E, Kuehl FA. Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci USA 1983; 80: 4349-4353.
28. Weller PF, Monahan-Earley RA, Dvorak HF, Dvorak AM. Cytoplasmatic lipid bodies of human eosinophils. Subcellular isolation and analysis of arachidonate incorporation. Am J Pathol 1991; 138: 141-148.
29. Dvorak AM, Morgan ES, Tzizik DM, Welier PF. Prostaglandin endoperoxide synthase (Cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmatic lipid bodies in human eosinophils and 3T3 fibroblasts. Arch Allergy Immunol 1994; 105: 245-250.
30. Meade EA, Smith WL, DeWitt DI. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs. J Biol Chem 1993; 268: 6610-6614.
31. 4, low IgG,. Clin Exp Allergy 1992; 22: 283-287.
32. Phipps RP, Stein SH, Roper RL. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991; 12: 351-352.